• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

HLA-DQB1*03:01 as a Biomarker for Genetic Susceptibility to Bullous Pemphigoid Induced by DPP-4 Inhibitors.

作者信息

Ujiie Hideyuki, Muramatsu Ken, Mushiroda Taisei, Ozeki Takeshi, Miyoshi Hideaki, Iwata Hiroaki, Nakamura Akinobu, Nomoto Hiroshi, Cho Kyu Yong, Sato Norihiro, Nishimura Machiko, Ito Takamasa, Izumi Kentaro, Nishie Wataru, Shimizu Hiroshi

机构信息

Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

出版信息

J Invest Dermatol. 2018 May;138(5):1201-1204. doi: 10.1016/j.jid.2017.11.023. Epub 2017 Dec 2.

DOI:10.1016/j.jid.2017.11.023
PMID:29203362
Abstract
摘要

相似文献

1
HLA-DQB1*03:01 as a Biomarker for Genetic Susceptibility to Bullous Pemphigoid Induced by DPP-4 Inhibitors.HLA-DQB1*03:01作为二肽基肽酶-4抑制剂诱导的大疱性类天疱疮遗传易感性的生物标志物。
J Invest Dermatol. 2018 May;138(5):1201-1204. doi: 10.1016/j.jid.2017.11.023. Epub 2017 Dec 2.
2
Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid, likely triggered by scabies, in a hemodialysis patient with human leukocyte antigen-DQB1*03:01.一名携带人类白细胞抗原-DQB1*03:01的血液透析患者发生二肽基肽酶-4抑制剂相关的大疱性类天疱疮，可能由疥疮引发。
CEN Case Rep. 2020 Aug;9(3):189-194. doi: 10.1007/s13730-020-00452-2. Epub 2020 Jan 28.
3
Bullous pemphigoid in a mother (DQB1*03:01:01) and daughter (DRB1*11:01) receiving antidiabetic drugs.一位母亲（DQB1*03:01:01）和女儿（DRB1*11:01）在接受抗糖尿病药物治疗时发生大疱性类天疱疮。
Eur J Dermatol. 2018 Feb 1;28(1):131-133. doi: 10.1684/ejd.2017.3097.
4
Alogliptin-induced bullous pemphigoid associated with HLA-DQB1*03:01: a case report.阿格列汀诱导的大疱性类天疱疮与HLA-DQB1*03:01相关：一例报告
Int J Dermatol. 2019 Jul;58(7):e132-e133. doi: 10.1111/ijd.14456. Epub 2019 Apr 10.
5
Association between HLA-DQB1*03:01 and Bullous pemphigoid in Iranian patients.伊朗患者中HLA-DQB1*03:01与大疱性类天疱疮之间的关联。
Iran J Immunol. 2013 Mar;10(1):1-9.
6
Gliptin-associated Bullous Pemphigoid and the Expression of Dipeptidyl Peptidase-4/CD26 in Bullous Pemphigoid.Gliptin 相关性大疱性类天疱疮与大疱性类天疱疮中二肽基肽酶 4/CD26 的表达。
Acta Derm Venereol. 2019 May 1;99(6):602-609. doi: 10.2340/00015555-3166.
7
HLA alleles associated to susceptibility to gliptin-associated bullous pemphigoid in Italian patients.与意大利患者吉列汀相关性大疱性类天疱疮易感性相关的 HLA 等位基因。
HLA. 2024 Aug;104(2):e15616. doi: 10.1111/tan.15616.
8
The HLA-DQB1*03:01 Is Associated with Bullous Pemphigoid in the Han Chinese Population.HLA-DQB1*03:01与中国汉族人群的大疱性类天疱疮相关。
J Invest Dermatol. 2018 Aug;138(8):1874-1877. doi: 10.1016/j.jid.2018.02.021. Epub 2018 Feb 27.
9
Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database.大疱性类天疱疮与二肽基肽酶-4 抑制剂：法国药物警戒数据库中的病例对照研究。
Br J Dermatol. 2016 Aug;175(2):296-301. doi: 10.1111/bjd.14601. Epub 2016 Jul 19.
10
Bullous pemphigoid and dermatitis herpetiformis association: a genetic predisposition.大疱性类天疱疮与疱疹样皮炎关联：一种遗传易感性。
J Dermatol. 2013 Nov;40(11):940-1. doi: 10.1111/1346-8138.12262. Epub 2013 Oct 16.

引用本文的文献

1
Identification of distinct epitopes in dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid.二肽基肽酶-4抑制剂相关大疱性类天疱疮中不同表位的鉴定
Sci Adv. 2025 Aug;11(31):eadv9423. doi: 10.1126/sciadv.adv9423. Epub 2025 Aug 1.
2
Recent advances in the genetics and innate immune cells of bullous pemphigoid.大疱性类天疱疮的遗传学和固有免疫细胞的最新进展。
Front Immunol. 2025 Jun 18;16:1530407. doi: 10.3389/fimmu.2025.1530407. eCollection 2025.
3
Evolving incretin-based therapies in Japan: optimizing treatment strategies for diverse clinical and socioeconomical profiles in type 2 diabetes.
日本基于肠促胰岛素疗法的发展：针对2型糖尿病不同临床和社会经济状况优化治疗策略
Diabetol Int. 2025 May 15;16(3):457-468. doi: 10.1007/s13340-025-00818-w. eCollection 2025 Jul.
4
Associated factors related to production of autoantibodies and dermo-epidermal separation in bullous pemphigoid.大疱性类天疱疮中与自身抗体产生及皮肤表皮分离相关的因素。
Arch Dermatol Res. 2025 Jan 24;317(1):303. doi: 10.1007/s00403-024-03760-0.
5
Enriched class II HLA inherence in patients with checkpoint inhibitor-associated bullous pemphigoid.检查点抑制剂相关大疱性类天疱疮患者中II类人类白细胞抗原富集遗传
Int J Dermatol. 2025 Feb;64(2):399-401. doi: 10.1111/ijd.17563. Epub 2024 Nov 26.
6
Association of HLA class II alleles and haplotypes with bullous and mucus membrane pemphigoid risk: A systematic review, a meta-analysis and a meta-regression.HLA Ⅱ类等位基因和单倍型与大疱性类天疱疮和黏膜性类天疱疮风险的关联：系统评价、荟萃分析和荟萃回归。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241296903. doi: 10.1177/03946320241296903.
7
HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessment.HLA遗传作为检查点抑制剂相关自身免疫性不良事件评估中的一个潜在参数。
Front Med (Lausanne). 2024 Jan 8;10:1288844. doi: 10.3389/fmed.2023.1288844. eCollection 2023.
8
From Molecular Insights to Clinical Perspectives in Drug-Associated Bullous Pemphigoid.从药物相关性大疱性表皮松解症的分子见解到临床观点。
Int J Mol Sci. 2023 Nov 26;24(23):16786. doi: 10.3390/ijms242316786.
9
Role of Human Leukocyte Antigen Class II in Antibody-Mediated Skin Disorders.人类白细胞抗原 II 类在抗体介导的皮肤疾病中的作用。
Medicina (Kaunas). 2023 Nov 4;59(11):1950. doi: 10.3390/medicina59111950.
10
Bullous pemphigoid triggered by dulaglutide: a case report and a review of the literature.度拉糖肽引发的大疱性类天疱疮：一例病例报告及文献综述
Dermatol Reports. 2023 Jun 6;15(3):9676. doi: 10.4081/dr.2023.9676. eCollection 2023 Sep 12.